chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Second shot arm soreness on the arm of the injection mostly in the joint for about 48 hours; Second shot arm soreness on the arm of the injection mostly in the joint for about 48 hours; drowsiness. I slept for about four hours after I got home.; This is a spontaneous report from a contactable consumer. This 66-Year-old male consumer reported for himself that he received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 17Feb2021 in right arm (at 66-year-old) as dose 2, single for COVID-19 immunization. The patient's medical history included heart from an unknown date and unknown if ongoing, digestive from an unknown date and unknown if ongoing, knee injuries from an unknown date and unknown if ongoing, post-traumatic stress disorder from an unknown date and unknown if ongoing ptsd and several others. The allergies were reported as none. The patient's concomitant medications were not reported. No other vaccine was received in four weeks. The patient received other medications in two weeks. The patient did not have Covid prior vaccination and was not tested for covid post vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN5318) via an unspecified route of administration on 27Jan2021 (at 66-year-old) on right arm as dose 1, single for COVID-19 immunization and experienced soreness to the injection site for like 5 hours, metallic taste in my mouth for a few minutes and metallic taste in my mouth for a few minutes. On 17Feb2021 after receiving the second shot the patient experienced soreness on the arm of the injection mostly in the joint for about 48 hours and drowsiness. He slept for about four hours after I got home. No treatment was received for events. On an unknown date in Feb2021 the patient recovered.  Information on Lot/Batch number has been requested  Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021228004 same patient/drug, different dose/event
Left arm Deltoid area, presented with cellulitis- 4cm presented with fever, chills achy body within of vaccine. 04/18/2005 Office visit, no erythema, or swelling. Pt well.
Liver problems; This spontaneous case was reported by an other health care professional and describes the occurrence of LIVER DISORDER (Liver problems) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIVER DISORDER (Liver problems). At the time of the report, LIVER DISORDER (Liver problems) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Hepatic enzyme increased: increased (High) increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered LIVER DISORDER (Liver problems) to be probably related.    No concomitant medications were reported. Treatment information was not provided. The patient had normal liver enzymes before. The patient  went for a routine visit to her PCP and she went for an ultrasound and after 13 vials of bloodwork and about 30 lab test they appeared  normal. The patient had a liver problem and it is probably  related to the immunization.
upon arising in the morning at approximately 4 AM this morning patient fell 3 times and was unable to get herself back up without the assistance of her husband.
This spontaneous report as received from a registered nurse refers to multiple patients of unknown age. The reporter reported that VAQTA (lot # reported as 1228, exp Jun 2014) which had been exposed to 31 degrees fahrenheit for 62 hours were administered to multiple unspecified patients on 20-OCT-2012. No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
After two days after the injection, I had pain. My entire arm started to hurt. It went to my forearm area. The doctor explained that they could've injected me wrong due to feeling of hardness in the area of the injection. I took a topical pain cream call diclofenac sodium topical gel 1%. I also took Tylenol 500mgs each, every 8 hours.
LARGE AREA 4 INCHES BY 3 INCHES ALL THE WAY DOWN THE ELBOW, RED ITCHING AND HURTS.
Uveitis in my left eye 6 days after vaccination. Treated with steroid eye drops, 4x a day. Same thing happened after my 1st booster (3rd shot) in October, 2021. Also treated with steroid eye drops as well as drops to address a rise in eye pressure.
Localized erythema and tenderness at site of vaccination onset 12/12/2009. On 12/12/29 patient complained of nerve pain on the outside of her right thigh to the knee.
Product storage error; Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (Product storage error) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment information were provided.
This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and was assigned a manufacturer report number. A 4 year old female with no  prior medical history or concurrent conditions  was vaccinated on 17Apr03 with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) SC in the right deltoid. Concomitant vaccination on 17Apr03 included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) SC in the left deltoid. There were no other concomitant medications. It was unknown if the pt had an illness at the time of vaccination. On 18Apr03, twenty four hours post vaccination, the pt developed an injection site reaction characterized by pain, swelling and inflammation at the injection site. The pt's left arm was stiff. The pt also developed irritability and a low grade fever. On 20Apr03 the pt recovered.   The nurse considered the events to be related to vaccination with diphtheria toxoid/pertussis vaccine/tetanus (INFANRIX). It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information was received from a RN who stated that the reaction was at the site of the diphtheria toxoid/ pertussis  vaccine/ tetanus (INFANRIX) in the deltoid. There was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) was that it was given at the same time. The reporter stated that to her knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment. No diagnostic work up or laboratory tests were performed.  The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid/ pertussis vaccine/ teta (INFANRIX). Additional information is not expected.
Patient in for her third Moderna shot.  Nurse looked at the immunocompromised chart and gave the patient a 0.5 3rd primary dose.   Determine the patient was not immunocompromised and should have gotten a 0.25 booster dose instead. Contacted immunization nurse consultant for instructions.
Pt at COVID vaccination clinic to receive Pfizer 20234-34 monovalent COVID vaccine. Patient visibly anxious with vaccinating nurse during screening questions; was physically jittery, talkative, and stating that they had a very stressful three months. Screening questions all responded in the negative and patient vaccinated in their left arm at 1655. Pt counseled to stay for 15 minutes after vaccination, per protocol. At 1725 patient noticed to still be in observation area and pacing. When approached by this nurse, patient stated they were "having an anxiety attack". Pt noted to be flushed in the face, denied any difficulty breathing, shortness of breath or throat/tongue swelling. Pt accompanied to a cubicle where VS taken. BP 128/98, HR 101, SaO299% on room air. Pt states "These are my symptoms when I have an anxiety attack, but I've never had it happen after getting vaccinated." Advised patient to take slow deep breaths, with pt appearing more calm and flushing in face starting to recede within several minutes.Agreed with patient to focus on breathing and calming techniques over the next 15 minutes at which point VS would be rechecked. After 15" pt states they feel much better. BP 128/96, HR 77, SaO2 99% on room air, flushing in face gone. Pt states that they were planning on taking the bus home, as that was their usual mode of transportation. Bus scheduled to arrive in 11 minutes. Pt stated that they felt well enough to go wait for bus. Pt counseled that if at any time while waiting for bus they felt unwell to come back in . Pt verbalized understanding and out of clinic ambulatory and unaccompanied at 1750.
15MAY 415PM t103.4 APAP given; still high fever called MD; 16-18MAY loss appetite; 19MAY devel measle rash & ear aches; 22MAY rash gone; 25MAY appetite almost back to nl;
Severe itching and hives started to both arms and spread to waist and trunk. Hives worsened significantly over 24 hours spreading to face and she developed difficulty swallowing.
The Problem: - For the two years prior to December 2021 fasting Blood Glucose levels were generally between 115 and 135 mg/dL, random Blood Glucose levels between 130 and 160 mg/dL and Hemoglobin A1c between 7.2% and 6.7%, - Two days after my Pfizer booster in December 2021 my fasting Blood Glucose levels rose to >250 mg/dL for the following week and did not go below 200 mg/dL until 6 weeks therafter, - April 2022: Calculated Mean Glucose was 189 mg/dL and Hemoglobin A1c 8.2 %, and - July 2022:  Calculated Mean Glucose was 169 mg/dL and Hemoglobin A1c 7.5 %.  As of now (July 2022) daily fasting and random Blood Glucose levels have returned to my normal baseline levels seen prior to the booster.  Pfizer COVID-19 Vaccine (COVID-19, mRNA, LNP-S, PF, 30mcg/0.3 mL dose - CARTON, 195 MULTI-DOSE VIALS),  LA  IM  EW0196  As of now (July 2022) daily fasting and random Blood Glucose levels have returned to my normal levels seen prior to the booster. I have not experienced any other adverse effects, never had Covid-19, never tested positive for Covid-19, nor have I had any illnesses (not even a cold) for the past several years.  No similar problem occurred after my original Pfizer vaccination (2 shots) received in October 2001 with only minor fluxuations noted in blood glucose levels.   Medical conditions: Type 2 diabetes and marginally high blood pressure (never above 155/110) and gernerally between 115/75 to 135/90.  Medications (Since May 2018): - Glyburide, 6mg, 1/day - Amlodipine Bestlate 5mg, 1/day - Lisinopril 20mg 1/day - Metformin 500mg x 2, twice daily.  I am an otherwise healthy male, 65 years, 195lbs, 6'2"; who exercises regularly 1-1.5 hours 5-days per week with weights, rows 10 miles per week and bicycles 5 miles/day 4 days per week. My eating and exercise habits have remained unchanged throughout the past 4-years.
Pt. developed non-raised red blotched with itching on lower arms, upper thighs and lower back 25 minutes, after receiving Yellow Fever vaccine. No other symptoms of allergic reaction or change in vital signs. Symptoms resolved 30 minutes after receiving oral BENADRYL.
Pt states about 2-3 days after injection her arm felt red and warm, told to put ice on it & take TYLENOL - 2 days later she went to ER where they lanced it & she had cellulitis & put on ABx- from there she heal well.
Seen 3/30 & reports that "several days after" injections started with swollen, painful, warm upper arm, started on LEVAQUIN, being re-evaluated today in office.
I received the shot and had the normal chills, body aches, and sore arm then on day 2 i broke out in a rash all over my torso, red raised macules  consistent with a drug rash.  i had no other symptoms no SOB, no swelling no hives.  Took zyrtec and benadryl  it was improved the next day and gone the following day.  I had a siimiliar incident when i received the shingrix shot on 9/16/2020.  i did not repeat that shot.  Wondering if I should repeat this one
This case was reported by a consumer via interactive digital media and described the occurrence of death in a 18-month-old male patient who received DTP (A or W not known) (DTP (A or W not known)) for prophylaxis. On an unknown date, the patient received DTP (A or W not known) at an unknown dose. On an unknown date, unknown after receiving DTP (A or W not known), the patient experienced death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the death was fatal. The reported cause of death was unknown cause of death. It was unknown if the reporter considered the death to be related to DTP (A or W not known). Additional information was reported as follows: This case was reported by a consumer via Interactive Digital Media. The age at vaccination was not reported. It was stated that the Dtap vaccine killed the patient, the patient was only 18 months old.; Reported Cause(s) of Death: Unknown cause of death.
0.5ml H1N1 administrated to child less than 36 mos instead of 0.25ml.
Guillain-Barre syndrome; Pain in her toes", "Pain in legs".; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (RA). The reporter is the parent.  A 50-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The patient's family history included mother "had hives" from fragrance, Propylene glycol (not Polyethylene glycol) and Balsam of Peru/from many years ago".  The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), outcome "unknown"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Pain in her toes", "Pain in legs".". Therapeutic measures were taken as a result of guillain-barre syndrome, pain in extremity.  Clinical information: Reporter reported that his 50-year-old daughter "developed Guillain-Barre syndrome 6 weeks after receiving a Pfizer Covid Vaccine. She continues to have Pain in her toes and legs and was now on medication." He stated it took 2 months for the doctors to diagnose. He also stated "she will probably have this forever. Reportedly, serious: no.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt vaccinated with TD developed Cellulitis vs large local reaction, fever but cultures were negative.
Felt like I was going to faint. Had to lie on the floor. Was taken to emergency room where it was stated that I had a vaso vagil reaction
pain in general in his joints & all over; tingling on the whole left side of his body; headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain in general in his joints & all over), PARAESTHESIA (tingling on the whole left side of his body), HEADACHE (headache) and FATIGUE (tired) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Previously administered products included for COVID-19 vaccination: J&J COVID vaccine (J&J as his primary dose). Past adverse reactions to the above products included No adverse event with J&J COVID vaccine.    On 13-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pain in general in his joints & all over), PARAESTHESIA (tingling on the whole left side of his body), HEADACHE (headache) and FATIGUE (tired). At the time of the report, PAIN (pain in general in his joints & all over), PARAESTHESIA (tingling on the whole left side of his body), HEADACHE (headache) and FATIGUE (tired) outcome was unknown.            Concomitant medication of the patient was not reported.   No treatment information was provided by the reporter. The reporter wanted to know, if the patient can take Tylenol.
The needle fails to retract after the immunization. I tried to recap and it went through the plastic cap and poke my left index finger.
Did not feel well; Fever; chills; I felt like I had the virus I was sick; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Did not feel well), ILLNESS (I felt like I had the virus I was sick), PYREXIA (Fever) and CHILLS (chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904, 001B21A and 031LZ0A) for COVID-19 prophylaxis.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Did not feel well), ILLNESS (I felt like I had the virus I was sick), PYREXIA (Fever) and CHILLS (chills). At the time of the report, MALAISE (Did not feel well), PYREXIA (Fever) and CHILLS (chills) outcome was unknown and ILLNESS (I felt like I had the virus I was sick) had resolved.            No medical history was reported by reporter.  The dose patient received on 01-Nov-2021 was patient's first Moderna Covid 19 vaccine booster.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-666051 (Linked Report). This case was linked to MOD-2022-666023, MOD-2022-666027 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-666051:Crosslinked with MOD22-028079 (Husband's case)
Nasal congestion/rhnitis onset evening after flu mist. Seen 10-9 with persistent congestion, wheezing and evidence bilat OM
Pain in (L) arm with localized redness and inflammation evident 2 days post inoculation. Pt states that although her arm is still very uncomfortable to use, it seems to be resolving on its own.
Sharp and severe Headache that comes and Goes though-out the day starting a bit more than a week from vaccination, never felt that headache before, the pain is located on the right side of head.  Had previously  the Johnson and johnson vaccine administered on november 1, 2021, this was a moderna booster dose.
Pt. is unclear which pneumonia shot she received and it was not given at this facility but through her primary provider on 4/4/2022.This provider did not see her until 4/13/2022 when she presented with "sinus pressure" and moderate to severe pain behind the left eye, in left parietal head region and anterior to the left auricle (8/10) and the transmandibular Joint of the left jaw.The pain radiated distally along left neck and to the left shoulder.Patient reported that the intractable pain started the day after receiving a vaccine (cont'd) for pneumonia"  and became so bad over the past 9 days that she went to the Emergency Room and underwent a diagnostic evaluation on 4/9/2022 @about 4pm for evaluation and treatment.ER MD ordered CT of Head without contrast and gave the following medications prior to discharge:  IV sodium chloride 0.9% (NS) bolus 1,000 ml;metoclopramide (REGLAN) injection 5 mg/mL (5 mg Intravenous;diphenhydrAMINE (BENADRYL) injection 50 mg/mL (25 mg Intravenous; dexamethasone (DECADRON) injection 4 mg/mL (8 mg Intravenous; and butalbital-acetaminophen-caffeine (FIORICET) per tablet (1 tablet Oral with a Rx of limited supply provided after discharge. When the pain persisted despite ER's interventions, member presented on 4/13/2022 in afternoon hours to this clinic for evaluation.  Patient was diagnosed with Sphenoidal Sinusitis on left and abnormal breath sounds.  She was prescribed Mucinex D prn as directed and Biaxin 500 mg i tab BID x 10 days.  This provider called the pt. this morning to check on her health status and she reported that she is starting to feel better.  The same pain in the various areas are still present but the level of intensity is now 3/10 and member reported that she has started to produce discolored thick phlegm since she started the antibiotic.  Member was also experiencing an exacerbation of her mod intermittent asthms that manifested as dyspnea with minimal physical exertion
kicked mx time by cow-mx abrasions; DT given; 2 days later called due to swelling of arm; markedly 3+ erythema & edema @ inject site; APAP & hot packs given;
My right armpit lymph node is really swollen and painful. Swelling started around 5 pm the day after the booster shot.
Presented with wekaness, fever, SOB; +Covid 15 days PTA; Dx Covid PNA; Labs: D-dimer: 2.35; Ferritin: 422;  CRP: 20.2; Lactic Acid 2.3    Tx:  supplemental O2; Tocilizumab, steroids, Vit C, Zinc, singulair, Tessalon Perles; No remdesivir as out of window to recieve. Home on O2 and continuing steroids
Initially slight headache, 5hrs later difficulty moving from waist down, 4/18/21 - tingling from waist down, went to ER no reflex response in both knees, 4/19/21 tingling in both arms, over a period of six days severe headache, lower body weakness,  nausea. When discharged still lower body weakness.  Since that time in May experienced 5/2021 complex hemiplegic migraine, lower body weakness waist down. Presently 6/2021 still lower body weakness and severe hemiplegic migraine, blurred vision.
Developed fever 101.4, red swollen area below injection site of PNEUMOVAX, hot to touch, pt experienced chills.